Five-year safety and efficacy data of natalizumab from the STRATA study

被引：0
|
作者：
Kappos, L.
Goodman, A.
Lublin, F.
O'Connor, P.
Polman, C.
Cristiano, L. M.
Forrestal, F.
Duda, P.
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ Rochester, Rochester, NY 14627 USA
[3] Mt Sinai Sch Med, New York, NY USA
[4] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[5] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[6] Biogen Idec Inc, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program)
    Simo Magdolna
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (5-6): : 211 - 212
  • [22] A five-year study of abortion
    Watkins, RE
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1933, 26 : 161 - 172
  • [23] Five-year, government funded, epidemiology study confirms safety of aspartame
    不详
    AGRO FOOD INDUSTRY HI-TECH, 2006, 17 (02): : XXIX - XXIX
  • [24] Five-year data from the Oxford Laser Prostatectomy Trial
    Keoghane, SR
    Sullivan, ME
    Doll, HA
    Kourambas, J
    Cranston, DW
    BJU INTERNATIONAL, 2000, 86 (03) : 227 - 228
  • [25] A Monocentric Analysis of Implantable Ports in Cancer Treatment: Five-Year Efficacy and Safety Evaluation
    Abou-Mrad, Adel
    Marano, Luigi
    Oviedo, Rodolfo J.
    CANCERS, 2024, 16 (16)
  • [26] Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
    Teal, Stephanie B.
    Turok, David K.
    Chen, Beatrice A.
    Kimble, Thomas
    Olariu, Andrea, I
    Creinin, Mitchell D.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (01): : 63 - 70
  • [27] Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease
    Brooks, David J.
    Leinonen, Mika
    Kuoppamaki, Mikko
    Nissinen, Helena
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (06) : 843 - 849
  • [28] Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson’s disease
    David J. Brooks
    Mika Leinonen
    Mikko Kuoppamäki
    Helena Nissinen
    Journal of Neural Transmission, 2008, 115 : 843 - 849
  • [29] Skin Tumors after Kidney Transplantation Five-Year Data from the TUMORAPA Study
    不详
    HAUTARZT, 2018, 69 (11): : 881 - 881
  • [30] Long-Term Safety Surveillance of Psychotropic Medications: A Five-Year Data from a Developing Country
    Lucca, Jisha Myalil
    Ramesh, Madan
    Raman, Rajesh
    Ram, Dushad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 378 - 378
12345